ChemoCentryx Inc. (CCXI)

10.78
0.11 1.00
NASDAQ : Health Technology
Prev Close 10.67
Open 10.75
Day Low/High 10.70 / 11.02
52 Wk Low/High 5.42 / 15.08
Volume 79.60K
Avg Volume 273.80K
Exchange NASDAQ
Shares Outstanding 49.07M
Market Cap 530.95M
EPS 0.40
P/E Ratio 30.06
Div & Yield N.A. (N.A)

Latest News

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

Small-cap stocks have finally jumped back to life on prospects for a strong U.S. economy this year. What trade war?

There's Only One Way to Effectively Trade This Crazy Stock Market

There's Only One Way to Effectively Trade This Crazy Stock Market

Forget resistance levels, oversold readings and everything else.

Commit To Purchase ChemoCentryx At $5, Earn 24.3% Annualized Using Options

Commit To Purchase ChemoCentryx At $5, Earn 24.3% Annualized Using Options

Investors eyeing a purchase of ChemoCentryx, Inc. shares, but cautious about paying the going market price of $8.45/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Oversold Conditions For ChemoCentryx (CCXI)

Oversold Conditions For ChemoCentryx (CCXI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

ChemoCentryx Enters Oversold Territory (CCXI)

ChemoCentryx Enters Oversold Territory (CCXI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Purchase ChemoCentryx At $8, Earn 14.4% Annualized Using Options

Commit To Purchase ChemoCentryx At $8, Earn 14.4% Annualized Using Options

Investors considering a purchase of ChemoCentryx, Inc. shares, but cautious about paying the going market price of $9.08/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Commit To Buy ChemoCentryx At $6, Earn 17.6% Annualized Using Options

Investors considering a purchase of ChemoCentryx, Inc. stock, but cautious about paying the going market price of $6.88/share, might benefit from considering selling puts among the alternative strategies at their disposal.

TheStreet Quant Rating: C+ (Hold)